CDKN2A and esophageal squamous cell carcinoma: Studies have indicated that p16 methylation and p53 mutations are frequently found in ESCC [19–23], suggesting that genetic and epigenetic alterations in p16 and p53 are involved in the pathogenesis of ESCC [18, 24].